Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuscale Power Corporation (SMR) vs 10X Genomics Inc (TXG) Price & Performance

Nuscale Power CorporationTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Nuscale Power Corporation vs 10X Genomics Inc — how do they compare? Nuscale Power Corporation trades at $8.87 (market cap $2.76B), while 10X Genomics Inc trades at $47.2 (market cap $5.48B). The key difference: 10X Genomics Inc is the larger of the two by market cap, and 10X Genomics Inc is trading nearer its 52-week high, Nuscale Power Corporation nearer its low. Which is the better fit depends on your goals.

SMRTXG
Market Cap
$2.76B$5.48B
Sector
UtilitiesHealth
52-Week High
$53.43$45.80
52-Week Low
$7.64$11.34
Enterprise Value
$1.87B$5.02B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nuscale Power Corporation

No Aura AI signal available yet.

10X Genomics Inc

TXG trades at $47.20, up 7.91% on the day, with a bullish technical signal from moving averages. The company reported Q1 2026 revenue that beat estimates, and net losses have narrowed significantly from -$255M in 2023 to -$44M in 2025. Operating cash flow turned strongly positive at $136M in 2025. Recent developments include the acquisition of Proteintech Genomics and a collaboration with Cleveland Clinic on bladder cancer diagnostics.

The outlook is mixed; improving fundamentals and strategic expansions support growth, but persistent net losses and a high EV/EBITDA of 133.91 pose valuation risks. Analyst consensus is divided with a $39.14 price target below the current price, indicating caution despite a majority buy/hold ratings.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nuscale Power Corporation

NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.

Read more on SMR

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG